Objectives: Deepen the understanding on the available topical treatments and get a clear picture on the multitude of conventional and new biologics on the market. and
Introduction: Psoriasis is a chronic inflammatory skin disease that severely affects patients’ quality of life. It is of particular relevance if areas such as the face, the scalp, the hands, nails and the genital area is affected. In recent years, a multitude of new treatment options have become available.
Materials / method: Systematic Reviews and Guidelines have been developed to guide practitioners through the plethora of new treatment options. The results from high quality systematic reviews and network-meta-analysis will be presented. Key recommendations from the guidelines will be summarized.
Results: The mainstay of topical treatment are topical corticosteroids and vitamin d and its analogues. As mycosis may play a role as an aggravating factor in the face and on the scalp, antimycotic treatment may be beneficial in these areas. Among the systemic conventional treatments, methotrexate and fumaric acid can be recommended, cyclosporine is another option, but its long term use is limited. Some of the biologics are achieving very high response rates, especially the group of anti IL17 and anti Il 23.
Conclusion: For everyday clinical practice with an aesthetic focus, topical corticosteroids and vitamin d as well as antimycotic treatements may play the major role. In case of moderate disease, the conventionals are the mainstay treatment. For severe disease, the biologics with high efficacy and a fast onset of action should be preferred.
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
否
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。